Brent Blackburn

Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial

Ami E. Iskandrian, Timothy M. Bateman, Luiz Belardinelli et al. · Journal of Nuclear Cardiology · 2007 · 341 citations

Multicenter International Trial, Radiology, Health Sciences +12

Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure

Hani N. Sabbah, Margaret P. Chandler, Takayuki Mishima et al. · Journal of Cardiac Failure · 2002 · 141 citations

Cardiomyopathy, Heart Failure, Chronic Heart Failure +11

Short-Term Treatment With Ranolazine Improves Mechanical Efficiency in Dogs With Chronic Heart Failure

Margaret P. Chandler, William C. Stanley, Hideaki Morita et al. · Circulation Research · 2002 · 139 citations

Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans

Hsiao D. Lieu, John C. Shryock, Gregory O. von Mering et al. · Journal of Nuclear Cardiology · 2007 · 138 citations

Thrombosis, Cardiovascular Disease, Medicine +10

Initial Clinical Experience With Regadenoson, a Novel Selective A2AAgonist for Pharmacologic Stress Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging

Robert C. Hendel, Timothy M. Bateman, Manuel D. Cerqueira et al. · Journal of the American College of Cardiology · 2005 · 127 citations

Engineering, Cardiovascular Translational Research, Medical Imaging +13